1 = 9), and regulators (n = 2) (3 participants
were included in 2 groups each), culminating in a consen
2 tors, and active section with phase shifters-
are included in a single metal layer.
3 ot provide enough statistical information to
be included in a meta-analysis, we did a narrative synth
4 score from the ICU admission day (ICU day 1)
was included in a multivariable model controlling for ot
5 endpoint, 30-day post-operative stroke rate,
were included in a Bayesian network meta-analysis.
6 ETHODS AND In Benin, 497 mother-infant pairs
were included in a longitudinal birth cohort.
7 such as donor type and conditioning regimen,
were included in a multivariate regression model.
8 f 16 studies published during 2004-2009 that
were included in a published conventional meta-analysis.
9 ase-control and two population-based studies
were included in a random effects meta-analysis.
10 r filtration rate, and total bilirubin level
were included in a simplified model and incorporated int
11 udy participants in the case detection group
were included in all analyses, whereas participants in t
12 who received at least one dose of study drug
were included in all analyses.
13 ke to help build a consensus for what should
be included in an internationally agreed protocol for CA
14 All patients who received treatment
were included in an intent-to-treat analysis of the resp
15 nical cutoffs.Data from 403,199 participants
were included in analyses.
16 170 articles from 16 countries
were included in analysis of efficacy of first-line ther
17 Large PVSs should
be included in assessments of vascular cognitive impairm
18 When present, lactisole
was included in both the preload and OGTT solutions.
19 the mesh trial, 13 in the graft trial; five
were included in both trials) and were included in the b
20 tom progression and to improve function must
be included in clinical and survivorship care plans.
21 equently, CYP2C19 genotype status should not
be included in clinical decisions on tamoxifen treatment
22 re largely uninformative and not eligible to
be included in efficacy meta-analyses.
23 ild food- and drink-sharing behaviors should
be included in efforts to minimize HHV-8 transmission, a
24 However, radiation dose, while relevant to
be included in estimating the risk associated with contr
25 framework for Total Diet Studies that could
be included in formal quality management systems.
26 article.)=97.5%) compared with 2D ((Equation
is included in full-text article.)=54.5%) [difference in
27 sis more often with 3D ultrasound ((Equation
is included in full-text article.)=97.5%) compared with
28 1,006 controls remained in the datasets and
were included in further analysis.
29 information about hospital safety and should
be included in hospital safety surveillance in order to
30 Forty-nine participants
were included in intention-to-treat analyses.
31 lar and 5928 open revascularization patients
were included in matched analysis.
32 6 completed treatment, had useable data, and
were included in most data analyses.
33 mortality exist, and tuberculosis has never
been included in official estimates of under-5 child mor
34 r, several patient-level variables could not
be included in our analysis because of high levels of mi
35 To
be included in our review, a study had to meet the follo
36 Of 4584 patients in the database, 2697
were included in our analysis (84.1% men; 87.6% Caucasia
37 60 publications
were included in our assessment.
38 Of 374 studies identified by our search, 30
were included in our study, only eight of which included
39 , suggesting cross-protection with 6A, which
is included in PCV13.
40 ants were included in video analyses, and 62
were included in picture analyses.
41 timates, we propose that the core markers to
be included in population models for other sites should
42 disoproxil fumarate regimen before screening
were included in primary efficacy analyses.
43 who received at least one dose of study drug
were included in primary efficacy and safety analyses.
44 13.8 QALMs versus strategy C when pertuzumab
was included in strategy C.
45 1.6 QALMs versus strategy C when palbociclib
was included in strategy C; similarly, strategy A had a
46 Seven trials
were included: in sum, 5,583 patients were randomized to
47 and future directions in the research field
are included in the comprehensive review.
48 age at menarche.A total of 515 Chilean girls
are included in the Growth and Obesity Cohort Study.
49 ommercially funded TAVR in the United States
are included in the Transcatheter Valve Therapy Registry
50 associated with the IV (IV-confounders) must
be included in the analysis, and not including observati
51 l by allowing more sources of variability to
be included in the calibration by minimizing the consump
52 ase, cyst rapture into the bile ducts should
be included in the differential diagnosis even in serone
53 AH should
be included in the differential diagnosis of solid-cysti
54 sence of a solid organ mass, lymphoma should
be included in the differential diagnosis.
55 showed that R. eriocalyx might be a spice to
be included in the European food additive list and used
56 Three groups of children could not
be included in the final analysis: 147 migrated out of t
57 h enables a distribution of conformations to
be included in the final model.
58 t panel (N = 12) agreed that 63 items should
be included in the guidance, with an additional 17 items
59 1, 1970, and November 1, 2014, consented to
be included in the Mayo Clinic amyloidosis database main
60 giotensin receptor blocker, should generally
be included in the pharmacologic therapy for hypertensio
61 ys significant complementary role and should
be included in the routine MR imaging protocols.
62 Consensus that an item should
be included in the set of minimum standards was defined
63 Of the 116 who consented to
be included in the study, 112 (97%, 95% CI 91-99) receiv
64 To
be included in the systematic review, ulcerative colitis
65 indicate that beta-lactam antibiotics should
be included in the treatment regimen as an adjunct antiv
66 h mutated RUNX1 and AML with BCR- ABL1, have
been included in the current update of the WHO classific
67 fluencing non-communicable diseases have not
been included in the plan.
68 Melbourne, Australia, from 2010 to 2013 has
been included in the study.
69 ac arrest of presumed cardiac cause that had
been included in the TTM-trial.
70 5-year clinical outcomes in patients who had
been included in the Veterans Affairs trial of on-pump v
71 Detailed analysis of the provided features
is included in the Supplementary Material .
72 not attend the placebo follow-up period, but
was included in the final analysis.
73 st when the strong effect of CR1 copy number
was included in the model.
74 Non-HLA antibody testing
was included in the posttransplant evaluation for 70 kid
75 rials and Methods A total of 1,206 survivors
was included in the study, together with 2,412 age-match
76 Long-term follow-up
was included in the third protocol amendment; 28 sites r
77 who received at least one dose of venetoclax
were included in the activity and safety analyses.
78 Visual Function Index (VF-11) data available
were included in the analyses for the present study.
79 n (mean age at baseline 56.5 years [SD 8.1])
were included in the analyses, with a mean follow-up of
80 enia and 4040 controls (1613 [39.9%] female)
were included in the analyses.
81 rction) fulfilled the inclusion criteria and
were included in the analyses.
82 from 1235 normal eyes of 830 study subjects
were included in the analyses.
83 d ungradable fundus images, 361 participants
were included in the analyses.
84 prevalence in adults aged 60 years or older
were included in the analyses.
85 Of the 1406 children in the study, 1323
were included in the analysis (mean [SD] age was 11.7 [0
86 atients who met the inclusion criteria, 2429
were included in the analysis (median age, 10 years; int
87 ation from 909 073 patients, of whom 550 083
were included in the analysis after processing.
88 signed to receive KGF and 31 to placebo; all
were included in the analysis of the primary outcome.
89 Of these, 1671
were included in the analysis sample.
90 21 treatment exposure variables
were included in the analysis, with data abstracted from
91 l pathology review; hence, 71 (95%) patients
were included in the analysis.
92 300 randomly selected individuals without AN
were included in the analysis.
93 , 85%) organisms targeted by the latter test
were included in the analysis.
94 LTs from January 1, 2010, to March 31, 2016,
were included in the analysis.
95 eline and at least once during follow-up and
were included in the analysis.
96 l, 638 patients treated with oral tacrolimus
were included in the analysis.
97 6 eyelid margin and 129 conjunctival lesions
were included in the analysis.
98 tivations for those decisions, and knowledge
were included in the analysis.
99 l History Project of the Dystonia Coalition,
were included in the analysis.
100 (intervention, n = 2993; control, n = 5999)
were included in the analysis.
101 SDOCT scans from 269 eyes (148 participants)
were included in the analysis.
102 Those who had attempted suicide
were included in the analysis.
103 21 met the initial eligibility criteria and
were included in the analysis.
104 d clinical trials were pooled; 4394 patients
were included in the analysis.
105 their treatment at the reporting institution
were included in the analysis.
106 -two RA cases (3069 radial and 5553 femoral)
were included in the analysis.
107 [17.1] years) from 13 cohorts in 6 countries
were included in the analysis.
108 eous cohort of HIC patients but also when PP
were included in the analysis.
109 with 363 dental implants in 262 participants
were included in the analysis.
110 Of 1088 patients screened, 879
were included in the analysis.
111 of 480 patients with bloodstream infections
were included in the analysis: 247 in the preinterventio
112 In the e-ROP study, 246 infants (492 eyes)
were included in the analysis; 138 (56.1%) were male.
113 Of these, 1301497 children
were included in the analysis; 641479 (49.3%) were girls
114 5086 participants (47 886 visits)
were included in the analytic sample (2278 HIV-seroposit
115 rial; five were included in both trials) and
were included in the baseline analyses only.
116 and/or ovarian cancers whose medical records
were included in the clinical database of a large quater
117 January 1, 2012, and December 31, 2013, who
were included in the Colectomy-Targeted American College
118 gational product in FREEDOM or the extension
were included in the combined safety analyses.
119 Among these, 200 monomicrobial cultures
were included in the comparative analysis.
120 A total of 945 eyes of 769 participants
were included in the Cornea Preservation Time Study that
121 Data from 285 individuals
were included in the database over a 15-year period.
122 ley National Health Service Foundation Trust
were included in the derivation (n = 33820) or external
123 214 patients with thrombotic microangiopathy
were included in the derivation cohort.
124 80 samples with phenotype and covariate data
were included in the discovery stage, whereas 922 sample
125 ) field and variable flip angle (FA) mapping
were included in the dynamic contrast-enhanced breast MR
126 enrolled in the extension with observed data
were included in the efficacy analyses.
127 t and at least one post-baseline measurement
were included in the efficacy analysis.
128 hallenge and at least one dose of study drug
were included in the efficacy analysis.
129 alence CI=-0.137 to -0.038) because both CIs
were included in the equivalence interval (-0.25 to 0.25
130 DAF present on at least 2 visits; these eyes
were included in the estimation of the progression of th
131 Overall, 1,352; 3,271; and 994 participants
were included in the etanercept, adalimumab, ustekinumab
132 patients, who satisfied inclusion criteria,
were included in the final analysis.
133 Of 732 patients enrolled, 730
were included in the final analysis.
134 al of 252 blood cultures, 126 in each group,
were included in the final analysis.
135 85 studies originally identified, 24 studies
were included in the final sample.
136 78% with moderate or severe liver steatosis]
were included in the follow-up intervention study (n = 1
137 g lacosamide and 442 taking carbamazepine-CR
were included in the full analysis set (took at least on
138 Neisseria gonorrhoeae, and Salmonella typhi
were included in the high-priority tier.
139 cipants (median age, 56 years; women, 61.9%)
were included in the intention-to-screen analyses.
140 A total of 3365 patients
were included in the intention-to-treat analyses (median
141 Of 155 patients randomized, 154
were included in the intention-to-treat analysis (doxycy
142 All participants
were included in the intention-to-treat analysis and per
143 e and 323 to doxorubicin alone), all of whom
were included in the intention-to-treat analysis.
144 tients underwent randomization, of whom 1435
were included in the intention-to-treat population.
145 tients (median age 55 years [IQR 45.0-65.5])
were included in the longitudinal study, 22 of whom had
146 onverted from MAC to GA during the procedure
were included in the MAC group.
147 Ten studies
were included in the meta- analysis of visual acuity, in
148 udies met the inclusion criteria; 20 studies
were included in the meta-analyses.
149 Eighteen studies
were included in the meta-analysis (11,216 observations)
150 Results Overall, 1,208 patients
were included in the meta-analysis (605 patients in the
151 original publications were screened, and 216
were included in the meta-analysis, comprising 15,219 in
152 A total of 712 studies were identified; 48
were included in the meta-analysis, of which 8 described
153 Nine studies (subject age range 30-97 years)
were included in the meta-analysis.
154 ; ten studies (22%) with 1769 patients (25%)
were included in the meta-analysis.
155 and manifest (n=191) HDGECs and HCs (n=333)
were included in the meta-analysis.
156 Fifty-three studies and 45900 patients
were included in the meta-analysis.
157 ine or oral placebo; of these patients, 4993
were included in the modified intention-to-treat analysi
158 Among 480 randomized participants, 465 (97%)
were included in the modified intention-to-treat analysi
159 181 (99%) of 183 children
were included in the modified intention-to-treat analysi
160 SD] age, 70 [7] years; 44 [15.1%] women) and
were included in the modified intention-to-treat analysi
161 of whom received levosimendan or placebo and
were included in the modified intention-to-treat populat
162 9%) of 230 patients in the risperidone group
were included in the modified intention-to-treat populat
163 eived product, underwent ETEC challenge, and
were included in the per protocol efficacy analysis.
164 Among the 3508 infants who
were included in the per-protocol efficacy analysis, the
165 Vi-PS group, and 37 in the Vi-TT group) and
were included in the per-protocol population.
166 y treatment), and 408 and 397, respectively,
were included in the per-protocol set.
167 PACITY trials and 555 from the ASCEND trial)
were included in the pooled analysis.
168 Women
were included in the present analysis if they fulfilled
169 t recipients at our institution, 15 subjects
were included in the present study.
170 nts underwent randomization and 4919 (98.5%)
were included in the primary analysis.
171 ENFS group and 47 patients in the sham group
were included in the primary analysis.
172 pest management education alone group), 334
were included in the primary analysis.
173 7 patients, of whom 18 306 underwent PCI and
were included in the primary analysis.
174 o received one or more doses of atezolizumab
were included in the primary and safety analyses.
175 a available at baseline and 1-year follow-up
were included in the primary and safety analysis.
176 ipants who received the dolutegravir regimen
were included in the primary efficacy analyses.
177 61 patients underwent randomization, and 328
were included in the primary efficacy analysis (132 in t
178 umab group and 209 in the teriparatide group
were included in the primary efficacy analysis.
179 of study drug during the maintenance period
were included in the primary efficacy and safety analyse
180 and all treated patients who were classified
were included in the primary endpoint analysis.
181 s and no medical history or signs of asthma,
were included in the randomized, double-blind, placebo-c
182 in the discovery stage, whereas 922 samples
were included in the replication stage.
183 A total of 20 papers
were included in the review, the majority of which were
184 A total of 21 studies
were included in the review.
185 78 articles
were included in the review.
186 treated with at least one dose of rucaparib
were included in the safety analyses and all treated pat
187 All participants
were included in the safety analyses.
188 eived at least one dose of pembrolizumab and
were included in the safety analyses.
189 t during their period of trial participation
were included in the safety analyses.
190 320 withdrew after one dose of vaccine, but
were included in the safety analyses.
191 1%] women; mean [SD] age, 38.3 [10.4] years)
were included in the safety analysis set.
192 atients who received at least one study dose
were included in the safety analysis set.
193 drug, with treatment assignment as treated,
were included in the safety analysis.
194 All randomly assigned patients
were included in the safety analysis.
195 to 30 mug, 50 to 60 mug, and 50 to placebo)
were included in the safety analysis.
196 or cariprazine and 231 for risperidone); 460
were included in the safety population (one patient disc
197 ved at least one dose of study treatment and
were included in the safety population.
198 When all five
were included in the same model, adjusted ORs for barium
199 When all of the QT-interval components
were included in the same model, T-wave onset to T-peak
200 en from 1997 through 2011; of these, 1424279
were included in the sample.
201 Forty-five patients
were included in the series, 19 with smooth-bordered les
202 repair arm assigned to all treatment options
were included in the standard repair group of both trial
203 A total of 3414 keratoplasty cases
were included in the statistical analysis.
204 A total of 181 patients with G1D
were included in the study (92 [50.8%] male and 89 femal
205 Overall, 743630 women
were included in the study (mean age, 28.1 [SD, 6.0] yea
206 a total of 498 cases with 12 month follow-up
were included in the study after applying the exclusion
207 14 women; mean [SD] age, 64.2 [10.1] years)
were included in the study analysis.
208 +/- 2.0 on a 10-point numeric rating scale)
were included in the study and randomly allocated to int
209 Laboratory reared P. papatasi
were included in the study as an insectarium population.
210 One hundred ninety-two patients
were included in the study cohort; median patient age wa
211 station officers supervised by each manager
were included in the study via their anonymised sickness
212 Two hospitals in Tanga Region, Tanzania
were included in the study, 1 randomly assigned to recei
213 Of the 48599 discharged patients who
were included in the study, 25 006 (51.4%) were female,
214 o required continuous temperature monitoring
were included in the study, after informed consent.
215 In total 450 patients younger than 50 years
were included in the study, and 75 gene mutations were f
216 A total of 3302 patients
were included in the study, with a median age of 50 year
217 sed with unilateral iris racemose hemangioma
were included in the study.
218 (11 eyes) had undergone vitreous surgery and
were included in the study.
219 A total of 775 patients
were included in the study.
220 eir baseline Jackson Heart Study examination
were included in the study.
221 rom June 1, 1991, through November 31, 2015,
were included in the study.
222 ian for at least 6 months; and spoke English
were included in the study.
223 and postinterventional esophageal endoscopy
were included in the study.
224 Ultimately, 1783 consecutive patients
were included in the study.
225 h RA, PsA, OA or IBD and 50 healthy controls
were included in the study.
226 with primary BCS referred for TIPS placement
were included in the study.
227 760 female [60.7%] and 28 971 male [39.3%])
were included in the study.
228 fever from November 2013 through August 2015
were included in the study.
229 o Ischaemic Heart Disease Risk Factor Study,
were included in the study.
230 les and 12 control photodamaged facial areas
were included in the study.
231 ne hundred and eighteen eyes of 118 patients
were included in the study.
232 easurements of cardiometabolic risk factors,
were included in the study.
233 dividuals, 17 normal eyes of 17 participants
were included in the study.
234 lready diagnosed with arterial hypertension)
were included in the study.
235 nters (Rochester, Phoenix, and Jacksonville)
were included in the study.
236 f 100 patients with malignant breast lesions
were included in the study.
237 out grade 2 or greater peripheral neuropathy
were included in the study.
238 72 females) met the eligibility criteria and
were included in the study.
239 A total of 61 patients
were included in the study.
240 or detection of ova) and 17 healthy controls
were included in the study.
241 A total of 353 patients
were included in the study.
242 a as well as those not receiving hydroxyurea
were included in the study.
243 Adults admitted with UGIB
were included in the study.
244 anical ventilation from May to November 2014
were included in the study.
245 xteen RCTs and 20 prospective cohort studies
were included in the systematic review.
246 All randomised patients
were included in the time to clinically meaningful deter
247 May 22, 2012, to Jan 31, 2014, 571 children
were included in the trial.
248 Significant factors
were included in the updated Lung-molGPA prognostic inde
249 Data for 663 women
were included in these analyses.
250 rued to four sequential studies of ibrutinib
were included in these analyses.
251 uce obtained directly from pomegranate juice
are included in this review.
252 opsy-proven PCa provided informed consent to
be included in this institutional human ethics board-app
253 (delayed-start group) in the RAPID-RCT trial
were included in this 2-year open-label extension trial
254 106 patients
were included in this analysis, 34 receiving apheresis a
255 eal melanoma (mean age, 57.98+/-14.75 years)
were included in this analysis, of whom 20 had no metast
256 stics, surgery procedure, and follow-up data
were included in this analysis.
257 FRANCE TAVI and 4,165 patients from FRANCE 2
were included in this analysis.
258 of gestation and again at 0-14 wk postpartum
were included in this analysis.
259 BSCR group and 59 eyes in the control group
were included in this analysis.
260 ging and Its Treatment with Anticoagulation)
were included in this analysis.
261 from the Food4Me randomized controlled trial
were included in this analysis.
262 whom 11 944 with intermediate-risk adenomas
were included in this analysis.
263 cardiovascular or valve disease at baseline
were included in this cohort study.
264 logically or MP radiologically, the patients
were included in this descriptive retro perspective stud
265 In all, 291 participants (92.4%)
were included in this multicenter prospective investigat
266 gen (PSA) levels after radical prostatectomy
were included in this retrospective analysis.
267 ed at our Liver Center between 2003 and 2014
were included in this retrospective analysis.
268 2002 and 2015 and genetic testing performed
were included in this retrospective cohort study.
269 ng with a 3-T imager at a single institution
were included in this retrospective study.
270 rmed for suspected vertebral bone metastases
were included in this retrospective, institutional revie
271 -synaptic neurons and glial cells; 60 papers
were included in this review.
272 Forty-six articles, from 28 countries,
were included in this review.
273 A total of 42 research papers
were included in this review.
274 complete risk factor and follow-up data and
were included in this study (mean [SD] age, 62.2 [10.2]
275 sed glioblastoma and four healthy volunteers
were included in this study from October 2015 to July 20
276 Videos
were included in this study only if residents demonstrat
277 r without cetuximab (NRG Oncology RTOG 0522)
were included in this study, and 413 patients with avail
278 ars of age and duration of less than 4 years
were included in this study.
279 hildren (aged 8-18 years) with IBS or FAP(S)
were included in this study.
280 Of 126 potentially eligible articles, 26
were included in this study.
281 (mean [SD] age, 1.9 [2.7] years; 438 girls)
were included in this study.
282 ACRIN 6678 (n = 34) and MK-0646-008 (n = 39)
were included in this study.
283 1 087 672 Danish people
were included in this study.
284 iduals, who had data available for analysis,
were included in this study.
285 tor profiles, and were free of clinical CVD,
were included in this study.
286 t surgery between January 2007 and June 2014
were included in this study.
287 CTA signal identified on en face OCTA images
were included in this study.
288 sciitis (n = 31; mean [SD] age, 54.3 [13.5])
were included in this study.
289 nstitution between August 2015 and June 2016
were included in this study.
290 patients with autoimmune blistering diseases
were included in this study; their mean (SD) age was 66.
291 2) years identified as having CNGB1 variants
were included in this study; there was a mean (SD) follo
292 Hershey Medical Center, 95 patients
were included in this systematic review.
293 Results Forty-one publications
were included in this systematic review.
294 iving treatment with alternative medications
were included in this trial.
295 Measures of patient functional status should
be included in trials to better assess fit versus frail
296 ge as a result of hematologic disease should
be included in trials.
297 inine clearance values of > 30 mL/min should
be included in trials.
298 It has
been included in various pharmaceutical products because
299 Sixty participants
were included in video analyses, and 62 were included in
300 inical trial, and five retrospective studies
were included in visual field meta-analysis.